US Stock MarketDetailed Quotes

WST West Pharmaceutical Services

Watchlist
  • 211.290
  • +1.030+0.49%
Close May 2 16:00 ET
  • 211.290
  • 0.0000.00%
Post 16:29 ET
15.18BMarket Cap33.17P/E (TTM)

West Pharmaceutical Services Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
0.37%698M
-1.92%2.89B
2.30%748.8M
-0.07%746.9M
-6.86%702.1M
-2.96%695.4M
2.18%2.95B
3.29%732M
8.81%747.4M
-2.27%753.8M
Operating revenue
0.37%698M
-1.92%2.89B
2.30%748.8M
-0.07%746.9M
-6.86%702.1M
-2.96%695.4M
2.18%2.95B
3.29%732M
8.81%747.4M
-2.27%753.8M
Cost of revenue
0.19%466.1M
4.07%1.89B
4.72%475.2M
5.03%482.2M
2.10%472.1M
4.47%465.2M
3.99%1.82B
1.61%453.8M
9.60%459.1M
2.80%462.4M
Gross profit
0.74%231.9M
-11.57%998.5M
-1.65%273.6M
-8.19%264.7M
-21.07%230M
-15.15%230.2M
-0.62%1.13B
6.14%278.2M
7.57%288.3M
-9.36%291.4M
Operating expense
0.00%104.3M
-3.37%407.6M
-4.24%103.8M
-6.07%99M
-4.19%100.5M
1.16%104.3M
12.36%421.8M
6.69%108.4M
31.91%105.4M
9.38%104.9M
Selling and administrative expenses
1.50%88M
-4.22%338.5M
-5.22%85.3M
-6.18%83.5M
-6.11%83M
0.81%86.7M
11.52%353.4M
5.02%90M
34.24%89M
8.47%88.4M
Research and development costs
-7.39%16.3M
1.02%69.1M
0.54%18.5M
-5.49%15.5M
6.06%17.5M
2.92%17.6M
16.92%68.4M
15.72%18.4M
20.59%16.4M
14.58%16.5M
Operating profit
1.35%127.6M
-16.47%590.9M
0.00%169.8M
-9.40%165.7M
-30.56%129.5M
-25.15%125.9M
-7.02%707.4M
5.79%169.8M
-2.76%182.9M
-17.33%186.5M
Net non-operating interest income expense
-19.57%3.7M
-12.63%16.6M
-31.71%5.6M
-33.90%3.9M
8.70%2.5M
76.92%4.6M
778.57%19M
583.33%8.2M
942.86%5.9M
264.29%2.3M
Non-operating interest income
-33.87%4.1M
-30.00%19.6M
-48.94%4.8M
-47.73%4.6M
-20.00%4M
29.17%6.2M
449.02%28M
224.14%9.4M
486.67%8.8M
1,150.00%5M
Non-operating interest expense
-75.00%400K
-66.67%3M
-166.67%-800K
-75.86%700K
-44.44%1.5M
-27.27%1.6M
13.92%9M
-29.41%1.2M
31.82%2.9M
50.00%2.7M
Other net income (expense)
-570.97%-20.8M
22.54%-22M
-7.14%-10.5M
-183.33%-5.1M
15.38%-3.3M
75.97%-3.1M
63.64%-28.4M
70.30%-9.8M
96.48%-1.8M
-230.00%-3.9M
Gain on sale of security
0.00%-1.2M
-8.51%-10.2M
54.69%-2.9M
-127.78%-4.1M
-566.67%-2M
-33.33%-1.2M
-329.27%-9.4M
-204.76%-6.4M
-357.14%-1.8M
-118.75%-300K
Special income (charges)
-1,093.75%-19.1M
52.17%-9.9M
-386.67%-7.3M
107.14%300K
61.76%-1.3M
86.21%-1.6M
37.27%-20.7M
95.07%-1.5M
-44.83%-4.2M
-409.09%-3.4M
-Less:Restructuring and merger&acquisition
1,780.00%18.8M
620.00%2.6M
258.33%1.9M
-285.71%-1.3M
433.33%1M
233.33%1M
-101.87%-500K
-104.65%-1.2M
-53.33%700K
76.92%-300K
-Less:Impairment of capital assets
-50.00%300K
----
----
----
----
-68.42%600K
----
----
----
----
-Write off
----
-23.96%7.3M
100.00%5.4M
-71.43%1M
-80.00%300K
----
54.84%9.6M
-41.30%2.7M
150.00%3.5M
--1.5M
-Gain on sale of property,plant,equipment
----
--0
--0
--0
--0
----
---11.6M
--0
--0
---2.2M
Other non- operating income (expenses)
-66.67%-500K
-211.76%-1.9M
84.21%-300K
-130.95%-1.3M
----
25.00%-300K
103.46%1.7M
-280.00%-1.9M
108.57%4.2M
-166.67%-200K
Income before tax
-13.27%110.5M
-16.12%585.5M
-1.96%164.9M
-12.03%164.5M
-30.39%128.7M
-19.32%127.4M
2.66%698M
30.69%168.2M
37.30%187M
-18.62%184.9M
Income tax
46.95%24.1M
-12.10%107.5M
6.67%36.8M
10.20%32.4M
-37.07%21.9M
-30.51%16.4M
6.63%122.3M
19.38%34.5M
44.12%29.4M
-21.27%34.8M
Earnings from equity interest net of tax
-20.93%3.4M
-16.95%14.7M
-39.39%2M
5.41%3.9M
-10.00%4.5M
-24.56%4.3M
-14.49%17.7M
3.13%3.3M
-22.92%3.7M
-9.09%5M
Net income
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
1.28%593.4M
33.01%137M
33.75%161.3M
-17.72%155.1M
Net income continuous Operations
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
1.28%593.4M
33.01%137M
33.75%161.3M
-17.72%155.1M
Minority interest income
Net income attributable to the parent company
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
1.28%593.4M
33.01%137M
33.75%161.3M
-17.72%155.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
1.28%593.4M
33.01%137M
33.75%161.3M
-17.72%155.1M
Basic earnings per share
-21.02%1.24
-15.41%6.75
-3.24%1.79
-13.82%1.87
-26.92%1.52
-16.49%1.57
1.40%7.98
34.06%1.85
33.95%2.17
-17.79%2.08
Diluted earnings per share
-20.65%1.23
-15.10%6.69
-2.73%1.78
-13.55%1.85
-26.70%1.51
-16.22%1.55
1.94%7.88
34.56%1.83
34.59%2.14
-16.94%2.06
Dividend per share
5.00%0.21
5.19%0.81
5.00%0.21
5.26%0.2
5.26%0.2
5.26%0.2
5.48%0.77
5.26%0.2
5.56%0.19
5.56%0.19
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 0.37%698M-1.92%2.89B2.30%748.8M-0.07%746.9M-6.86%702.1M-2.96%695.4M2.18%2.95B3.29%732M8.81%747.4M-2.27%753.8M
Operating revenue 0.37%698M-1.92%2.89B2.30%748.8M-0.07%746.9M-6.86%702.1M-2.96%695.4M2.18%2.95B3.29%732M8.81%747.4M-2.27%753.8M
Cost of revenue 0.19%466.1M4.07%1.89B4.72%475.2M5.03%482.2M2.10%472.1M4.47%465.2M3.99%1.82B1.61%453.8M9.60%459.1M2.80%462.4M
Gross profit 0.74%231.9M-11.57%998.5M-1.65%273.6M-8.19%264.7M-21.07%230M-15.15%230.2M-0.62%1.13B6.14%278.2M7.57%288.3M-9.36%291.4M
Operating expense 0.00%104.3M-3.37%407.6M-4.24%103.8M-6.07%99M-4.19%100.5M1.16%104.3M12.36%421.8M6.69%108.4M31.91%105.4M9.38%104.9M
Selling and administrative expenses 1.50%88M-4.22%338.5M-5.22%85.3M-6.18%83.5M-6.11%83M0.81%86.7M11.52%353.4M5.02%90M34.24%89M8.47%88.4M
Research and development costs -7.39%16.3M1.02%69.1M0.54%18.5M-5.49%15.5M6.06%17.5M2.92%17.6M16.92%68.4M15.72%18.4M20.59%16.4M14.58%16.5M
Operating profit 1.35%127.6M-16.47%590.9M0.00%169.8M-9.40%165.7M-30.56%129.5M-25.15%125.9M-7.02%707.4M5.79%169.8M-2.76%182.9M-17.33%186.5M
Net non-operating interest income expense -19.57%3.7M-12.63%16.6M-31.71%5.6M-33.90%3.9M8.70%2.5M76.92%4.6M778.57%19M583.33%8.2M942.86%5.9M264.29%2.3M
Non-operating interest income -33.87%4.1M-30.00%19.6M-48.94%4.8M-47.73%4.6M-20.00%4M29.17%6.2M449.02%28M224.14%9.4M486.67%8.8M1,150.00%5M
Non-operating interest expense -75.00%400K-66.67%3M-166.67%-800K-75.86%700K-44.44%1.5M-27.27%1.6M13.92%9M-29.41%1.2M31.82%2.9M50.00%2.7M
Other net income (expense) -570.97%-20.8M22.54%-22M-7.14%-10.5M-183.33%-5.1M15.38%-3.3M75.97%-3.1M63.64%-28.4M70.30%-9.8M96.48%-1.8M-230.00%-3.9M
Gain on sale of security 0.00%-1.2M-8.51%-10.2M54.69%-2.9M-127.78%-4.1M-566.67%-2M-33.33%-1.2M-329.27%-9.4M-204.76%-6.4M-357.14%-1.8M-118.75%-300K
Special income (charges) -1,093.75%-19.1M52.17%-9.9M-386.67%-7.3M107.14%300K61.76%-1.3M86.21%-1.6M37.27%-20.7M95.07%-1.5M-44.83%-4.2M-409.09%-3.4M
-Less:Restructuring and merger&acquisition 1,780.00%18.8M620.00%2.6M258.33%1.9M-285.71%-1.3M433.33%1M233.33%1M-101.87%-500K-104.65%-1.2M-53.33%700K76.92%-300K
-Less:Impairment of capital assets -50.00%300K-----------------68.42%600K----------------
-Write off -----23.96%7.3M100.00%5.4M-71.43%1M-80.00%300K----54.84%9.6M-41.30%2.7M150.00%3.5M--1.5M
-Gain on sale of property,plant,equipment ------0--0--0--0-------11.6M--0--0---2.2M
Other non- operating income (expenses) -66.67%-500K-211.76%-1.9M84.21%-300K-130.95%-1.3M----25.00%-300K103.46%1.7M-280.00%-1.9M108.57%4.2M-166.67%-200K
Income before tax -13.27%110.5M-16.12%585.5M-1.96%164.9M-12.03%164.5M-30.39%128.7M-19.32%127.4M2.66%698M30.69%168.2M37.30%187M-18.62%184.9M
Income tax 46.95%24.1M-12.10%107.5M6.67%36.8M10.20%32.4M-37.07%21.9M-30.51%16.4M6.63%122.3M19.38%34.5M44.12%29.4M-21.27%34.8M
Earnings from equity interest net of tax -20.93%3.4M-16.95%14.7M-39.39%2M5.41%3.9M-10.00%4.5M-24.56%4.3M-14.49%17.7M3.13%3.3M-22.92%3.7M-9.09%5M
Net income -22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M1.28%593.4M33.01%137M33.75%161.3M-17.72%155.1M
Net income continuous Operations -22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M1.28%593.4M33.01%137M33.75%161.3M-17.72%155.1M
Minority interest income
Net income attributable to the parent company -22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M1.28%593.4M33.01%137M33.75%161.3M-17.72%155.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M1.28%593.4M33.01%137M33.75%161.3M-17.72%155.1M
Basic earnings per share -21.02%1.24-15.41%6.75-3.24%1.79-13.82%1.87-26.92%1.52-16.49%1.571.40%7.9834.06%1.8533.95%2.17-17.79%2.08
Diluted earnings per share -20.65%1.23-15.10%6.69-2.73%1.78-13.55%1.85-26.70%1.51-16.22%1.551.94%7.8834.56%1.8334.59%2.14-16.94%2.06
Dividend per share 5.00%0.215.19%0.815.00%0.215.26%0.25.26%0.25.26%0.25.48%0.775.26%0.25.56%0.195.56%0.19
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More